Single Use Bioprocessing Market

The global single-use bioprocessing market is projected to reach USD 34.9 billion by 2029 from USD 17.7 billion in 2024, at a CAGR of 14.5% during the forecast period of 2024 to 2029. Growth in the single-use bioprocessing market can be attributed to factors such as growing adoption among CDMOs & CMOs, increased productivity & reduced risk of cross contamination, reduced capital investment, and more environmental sustainability due to reduced water and energy consumption, among others. On the other hand, issues related to leachables & extractables, regulatory compliance issues, and impact of PFAS restrictions on product development are expected to hinder market growth.

The global single-use bioprocessing market is competitive, with Sartorius AG (Germany), Danaher Corporation (US), Thermo Fisher Scientific, Inc. (US) and Merck KGaA (Germany) accounting for the 44-48% of the market share globally.

To know about the assumptions considered for the study download the pdf brochure

Merck KGaA is one of the leading player in the single-use bioprocessing market. The company has focused on strengthening its global presence & position by offering a wide range of single-use bioprocessing products for end users operating in the single-use bioprocessing market. With a strong geographic reach, a broad portfolio of single-use bioprocessing products, and continuous expansion in developed as well as developing regions, the company is expected to grow at a high rate in the single-use bioprocessing market during the forecast period.

Danaher Corporation became one of the most prominent players in the single-use bioprocessing market after its acquisition of Pall Corporation. The company operates as one of the top players in the single-use bioprocessing market with its strong portfolio of single-use bioreactors, filtration systems, consumables, among others. Danaher Corporation focuses on growth strategies such as agreements, acquisitions, and expansions to strengthen its global position in the market. For instance, in the last three years, Danaher has engaged in acquisitions and agreements with Austar LifeSciences (China), Servier Laboratories (France), New Jersey Innovation Institute (US), General Electric-Life Sciences (US), and Sartorius AG (Germany).

Sartorius AG is among the top players operating in the single-use bioprocessing market with a wide range of single-use bioprocessing products addressing the needs of CROs, CDMOs, and pharma & biopharma companies. High investment in R&D has enabled the company to launch products such as Sartolab RF|BT Vacuum Filtration Units for single-use bioprocessing applications. Further, the company has actively engaged in strategic expansions owing to the increasing demand for its products.

Related Reports:

Single Use Bioprocessing Market by Product (Equipment (Bioreactors, Mixers, Filtration, Chromatography), Consumables (Filters, Bags, Assemblies, Sensors)), Application, Workflow, Molecule Type (mAbs, Vaccines, CGT, Peptides) - Global Forecast to 2029

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]